Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Price, News & Analysis

Company Overview

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity. The SPAC structure provides a pool of cash and public equity to support target companies in biopharmaceuticals, medical devices, diagnostics and other related segments of the life sciences industry.

Since completing its initial public offering in December 2020, OACC has been actively evaluating potential targets worldwide, with a primary focus on North America and Europe. The company’s search criteria emphasize businesses with innovative product pipelines, scalable platforms and strong management teams capable of addressing significant unmet medical needs. OACC’s board and management team draw on Oaktree Capital’s deep industry expertise and global network to assess opportunities, structure transactions and support acquired companies through post-closing integration.

Governance and oversight are provided by a board of directors and executive officers that include senior professionals affiliated with Oaktree Capital Management. Leveraging the sponsor’s rigorous due-diligence framework and operational support, OACC seeks to deliver long-term value for public shareholders by combining financial discipline with strategic guidance tailored to life sciences enterprises. The SPAC format offers target companies a streamlined path to public markets, enhanced visibility and access to growth capital under the oversight of an experienced sponsor.

Key Stats

• Today's Range: $10.48 to $10.50
• 50-Day Range: $10.30 to $10.49
• 52-Week Range: $9.95 to $10.85
• Volume: 81,141 shs
• Average Volume: 97,814 shs
• Market Capitalization: $235.19 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OACC Stock Analysis - Frequently Asked Questions

How have OACC shares performed this year?

Oaktree Acquisition Corp. III Life Sciences' stock was trading at $10.01 at the start of the year. Since then, OACC shares have increased by 4.8% and is now trading at $10.49.

Who are Oaktree Acquisition Corp. III Life Sciences' major shareholders?

Top institutional shareholders of Oaktree Acquisition Corp. III Life Sciences include Lighthouse Investment Partners LLC (3.79%), Moore Capital Management LP (2.34%), Alberta Investment Management Corp (2.23%) and Sculptor Capital LP (2.23%).

How do I buy shares of Oaktree Acquisition Corp. III Life Sciences?

Shares of OACC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Financial Services
• Industry: Investment Offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:OACC
• CIK: 2029769
• Web: N/A
• Phone: (213) 830-6300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 22,420,000
• Free Float: N/A
• Market Cap: $235.19 million
• Optionable: N/A
• Beta: N/A